Last updated on February 2020

Plaque Psoriasis (Pill) Study

Brief description of study

A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Mild to Moderate Plaque Psoriasis


Clinical Study Identifier: TX217788

Find a site near you

Start Over

Clinical Trials Management, LLC

3801 Houma Blvd. Suite 200 Metairie, LA United States
  Connect »